Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis

PURPOSE: Hangeshashinto (TJ-14, a Kampo medicine), which reduces the level of prostaglandin E2 and affects the cyclooxygenase activity, alleviates chemotherapy-induced oral mucositis (COM). We conducted a double-blind, placebo-controlled, randomized comparative trial to investigate whether TJ-14 pre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Chemother Pharmacol
Main Authors: Matsuda, Chu, Munemoto, Yoshinori, Mishima, Hideyuki, Nagata, Naoki, Oshiro, Mitsuru, Kataoka, Masato, Sakamoto, Junichi, Aoyama, Toru, Morita, Satoshi, Kono, Toru
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4485889/
https://ncbi.nlm.nih.gov/pubmed/25983022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-015-2767-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados